Literature DB >> 6806319

Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins.

P A Rice, D L Kasper.   

Abstract

Neisseria gonorrhoeae isolated from patients with disseminated infection (DGI) often resist complement (C')-dependent killing by normal human serum (NHS) and less commonly by convalescent DGI serum. 7 of 10 NHS specimens completely inhibited killing of serum-resistant (ser(r)) gonococci by convalescent or immune DGI serum. Immunoglobulin G (IgG) purified from NHS was shown to be the blocking agent. In addition, IgM (plus C') purified from NHS was shown to be fivefold more effective (wt/wt) in killing serum-sensitive (ser(s)) gonococci than equivalent amounts of IgM tested in the presence of IgG (whole serum). Although inhibition of NHS killing of ser(s) gonococci required a 640% excess of IgG, only a 40% excess was required to block immune serum killing of ser(r) gonococci. F(ab')(2) prepared from IgG also blocked killing of ser(r) gonococci by immune serum indicating antigenic specificity of blocking IgG.IgG immunoconcentrated against outer membrane protein (OMP) derived from ser(r) gonococci showed 40-fold increased blocking activity over normal IgG (wt/wt) and lacked antibody activity directed against gonococcal lipopolysaccharide by ELISA. Using direct immunoabsorption of IgG with purified gonococcal OMP; ser(r)-OMP was found sixfold more effective than ser(s)-OMP in neutralizing the blocking of immune serum killing of ser(r) gonococci, and 10-fold more effective in systems that used excess blocking IgG, NHS, and ser(s) gonococci. Blocking IgG preabsorbed with whole ser(r) gonococci lost 75% of its ability to block immune serum killing compared with no loss in this system using a similar absorption with ser(s) gonococci. IgG purified from NHS contained fivefold higher titers of antibody against ser(r)-OMP than ser(s)-OMP by ELISA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806319      PMCID: PMC370238          DOI: 10.1172/jci110589

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

3.  Blocking serum lysis of Brucella abortus by hyperimmune rabbit immunoglubulin A.

Authors:  W H Hall; R E Manion; H H Zinneman
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A factor in the serum of patients with persisting infection that inhibits the bactericidal activity of normal serum against the organism that is causing the infection.

Authors:  B A Waisbren; I Brown
Journal:  J Immunol       Date:  1966-09       Impact factor: 5.422

6.  Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera.

Authors:  J M Griffiss
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

7.  Affinity chromatography of anti-meningococcal antiserum.

Authors:  J L Winkelhake; D L Kasper
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

8.  Human immunity to the meningococcus. II. Development of natural immunity.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers.

Authors:  W J Yount; M M Dorner; H G Kunkel; E A Kabat
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  31 in total

1.  An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  Sarika Agarwal; Viviana P Ferreira; Claudio Cortes; Michael K Pangburn; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 2.  Systemic gonococcal infection.

Authors:  J D Ross
Journal:  Genitourin Med       Date:  1996-12

3.  Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides.

Authors:  R Mandrell; H Schneider; M Apicella; W Zollinger; P A Rice; J M Griffiss
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 4.  Molecular basis for serum resistance in Neisseria gonorrhoeae.

Authors:  P A Rice
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 5.  Interactions of Neisseria gonorrhoeae with human neutrophils.

Authors:  R F Rest; W M Shafer
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 6.  Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  P Densen
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

7.  Antigenic heterogeneity of lipid A of Haemophilus influenzae.

Authors:  M A Apicella; K C Dudas; A Campagnari; P Rice; J M Mylotte; T F Murphy
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

Review 8.  The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.

Authors:  Jennifer L Edwards; Michael A Apicella
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Neisserial porins inhibit human neutrophil actin polymerization, degranulation, opsonin receptor expression, and phagocytosis but prime the neutrophils to increase their oxidative burst.

Authors:  R Bjerknes; H K Guttormsen; C O Solberg; L M Wetzler
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

10.  Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae.

Authors:  D M Musher; A Goree; R E Baughn; H H Birdsall
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.